🇺🇸 FDA
Patent

US 11319298

Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor

granted A61PA61P25/00A61P25/16

Quick answer

US patent 11319298 (Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor) held by MSD R&D (China) Co. Ltd. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MSD R&D (China) Co. Ltd.
Grant date
Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00, A61P25/16, A61P25/18, A61P25/28